Technology Innovations and Growth Opportunities for Microbiome Technologies, COVID-19 Management, Gene Therapy, and Diabetes Management

Technology Innovations and Growth Opportunities for Microbiome Technologies, COVID-19 Management, Gene Therapy, and Diabetes Management

RELEASE DATE
22-May-2020
REGION
Global
Research Code: D759-00-14-00-00
SKU: HC03295-GL-TA_24418

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03295-GL-TA_24418

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent advances in microbiome technologies, COVID-19 management, cancer treatment, diabetes care, and non-invasive diagnostics. The TOE also provides a list of key industry influencers driving these innovations.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Probiotic, Probi, CRISPR-Cas, microbiome, Locus Biosciences, Cell Biotech, bacteria, AOBiome, skin care, MatriSys, Azitra, fungal infection, DermBiont, Micreos, S-Biomedic, acne, aging, dandruff, COVID-19, acute respiratory distress, Alung, Rome, Dark Genome, Yale, Human Longevity, Gilead, Sherlock Biosciences, BioMarin, Stanford, diabetes, urinary tract infection, Ulsan, Sorrento, antibody, E3 Ligase, Vividion, California, vitamin C, Duke, Alzheimer’s, Kevraza, Regeneron, Blood Filter, Baxter, Atea, endometrial cancer

Table of Contents

Recent Advances Fuelling Life Sciences, Health & Wellness

  • Patented and Clinically Documented Probiotic Strains
  • The Next-generation Probiotic
  • Precision CRISPR-Cas Bacteriophage for Targeted Microbial Killing
  • Precision Antibacterial Treatment
  • Novel Dual Coating Technology to Protect Probiotics
  • Cutting-edge Technology to Protect Probiotics
  • Restoring Human Health through Ammonia-oxidizing Bacteria
  • Ammonia-oxidizing Bacteria-based Cosmetics
  • Microbial Therapeutics and Skin Care Products
  • Clinically Advanced Microbial Products
  • Novel Therapeutics to Treat Adverse Skin Conditions
  • Genetically Modified Microbes for Skin Conditions
  • Skin Microbiome Therapeutics for Treatment of Fungal Infections
  • Pioneering Bioinformatics Platform for Treatment of Fungal Infections
  • Novel Bacteriophage-based Targeted Antimicrobials
  • Next Generation Antibiotics
  • Probiotic Treatment for Acne, Aging, and Dandruff
  • Patented Technology for Skin Care
  • Saliva-based Sampling for Enhanced COVID-19 Tests
  • Containing SARS-CoV-2 Infection
  • Treating Acute Respiratory Distress
  • Enabling Improved Extracorporeal Therapy
  • Repeatome-based Treatments for Autoimmune Diseases and Cancer
  • Lighting up the Dark Genome
  • Next Generation Scanning for Accurate Health Prediction
  • Increasing Healthy Life Span with the Help of Data
  • Large Scale Manufacturing of Remdesivir for Treatment of COVID-19
  • Preparedness to Manufacture Anti-viral Drug
  • CRISPR-based Testing Kit for COVID-19
  • Minimizing Efforts for COVID19 Diagnosis
  • Collaboration for Leveraging Gene Therapy Research
  • Expanding the Scope of Gene Therapy
  • Dual-hormone Replacement Treatment for Diabetes
  • Key Takeaway
  • Point-of-care Diagnosis of Urinary Tract Infection
  • Key Takeaway
  • Antibody Cocktail Against COVID-19
  • Preventive Antibody to Delay Virus Attack
  • Novel E3 Ligases Research Reaches Preclinical Stage
  • Ligases Broaden Scope for Exploratory Research
  • Using Vitamin C to Delay Tumor Progression
  • Fasting Mimicking to Help Manipulate Cancer Cells
  • Imaging Technology to Detect Alzheimer’s Disease
  • Understanding Signaling of the Central Nervous System
  • Repurposing Kevraza for COVID-19
  • Emerging Antibody Platform for COVID-19
  • Blood Filter for Reduction of Pro-inflammatory Cytokines
  • Enabling Improved Critical Care
  • Developing Oral Antiviral for COVID-19
  • Inhibiting Viral Reproduction in Human Hosts
  • Endometrial Cancer Diagnosis by Non-invasive Method
  • Key Takeaway

Industry Contacts

  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent advances in microbiome technologies, COVID-19 management, cancer treatment, diabetes care, and non-invasive diagnostics. The TOE also provides a list of key industry influencers driving these innovations. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Probiotic, Probi, CRISPR-Cas, microbiome, Locus Biosciences, Cell Biotech, bacteria, AOBiome, skin care, MatriSys, Azitra, fungal infection, DermBiont, Micreos, S-Biomedic, acne, aging, dandruff, COVID-19, acute respiratory distress, Alung, Rome, Dark Genome, Yale, Human Longevity, Gilead, Sherlock Biosciences, BioMarin, Stanford, diabetes, urinary tract infection, Ulsan, Sorrento, antibody, E3 Ligase, Vividion, California, vitamin C, Duke, Alzheimer’s, Kevraza, Regeneron, Blood Filter, Baxter, Atea, endometrial cancer
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-14-00-00
Is Prebook No
Ti Codes D759